{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["De Pasquale D"],"funding":["Associazione Italiana per la Ricerca sul Cancro"],"pagination":["e2203120"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11468287"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(19)"],"pubmed_abstract":["Glioblastoma multiforme (GBM) is the deadliest brain tumor, characterized by an extreme genotypic and phenotypic variability, besides a high infiltrative nature in healthy tissues. Apart from very invasive surgical procedures, to date, there are no effective treatments, and life expectancy is very limited. In this work, an innovative therapeutic approach based on lipid-based magnetic nanovectors is proposed, owning a dual therapeutic function: chemotherapy, thanks to an antineoplastic drug (regorafenib) loaded in the core, and localized magnetic hyperthermia, thanks to the presence of iron oxide nanoparticles, remotely activated by an alternating magnetic field. The drug is selected based on ad hoc patient-specific screenings; moreover, the nanovector is decorated with cell membranes deriv"],"journal":["Advanced healthcare materials"],"pubmed_title":["A Novel Patient-Personalized Nanovector Based on Homotypic Recognition and Magnetic Hyperthermia for an Efficient Treatment of Glioblastoma Multiforme."],"pmcid":["PMC11468287"],"funding_grant_id":["AIRCIG2020","ID24454"],"pubmed_authors":["Fiaschi P","Leoncino L","De Pasquale D","Desii A","Amadio S","Ciofani G","Marino A","Debellis D","Pucci C","Moscato S","Prior A","Prato M"],"additional_accession":[]},"is_claimable":false,"name":"A Novel Patient-Personalized Nanovector Based on Homotypic Recognition and Magnetic Hyperthermia for an Efficient Treatment of Glioblastoma Multiforme.","description":"Glioblastoma multiforme (GBM) is the deadliest brain tumor, characterized by an extreme genotypic and phenotypic variability, besides a high infiltrative nature in healthy tissues. Apart from very invasive surgical procedures, to date, there are no effective treatments, and life expectancy is very limited. In this work, an innovative therapeutic approach based on lipid-based magnetic nanovectors is proposed, owning a dual therapeutic function: chemotherapy, thanks to an antineoplastic drug (regorafenib) loaded in the core, and localized magnetic hyperthermia, thanks to the presence of iron oxide nanoparticles, remotely activated by an alternating magnetic field. The drug is selected based on ad hoc patient-specific screenings; moreover, the nanovector is decorated with cell membranes deriv","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jul","modification":"2026-06-02T04:54:36.955Z","creation":"2025-04-04T11:03:55.138Z"},"accession":"S-EPMC11468287","cross_references":{"pubmed":["37058273"],"doi":["10.1002/adhm.202203120"]}}